Zisapel; Nava

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zisapel; Nava.The latest application filed is for "melatonin mini-tablets and method of manufacturing the same".

Company Profile

0.24.21

Zisapel; Nava - Tel Aviv IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Melatonin mini-tablets and method of manufacturing the same Grant 10,869,857 - Laudon , et al. December 22, 2	2020-12-22
Melatonin mini-tablets and method of manufacturing the same Grant 10,849,856 - Laudon , et al. December 1, 2	2020-12-01
Melatonin Mini-tablets And Method Of Manufacturing The Same App 20200306193 - LAUDON; Moshe ; et al.	2020-10-01
Melatonin Mini-tablets And Method Of Manufacturing The Same App 20200306227 - LAUDON; Moshe ; et al.	2020-10-01
Melatonin mini-tablets and method of manufacturing the same Grant 10,722,494 - Laudon , et al.	2020-07-28
Melatonin Mini-tablets And Method Of Manufacturing The Same App 20190060277 - LAUDON; Moshe ; et al.	2019-02-28
CD44 splice variants in neurodegenerative diseases Grant 9,416,166 - Pinner , et al. August 16, 2	2016-08-16
Cd44 Splice Variants In Neurodegenerative Diseases App 20150266940 - Pinner; Elhanan ; et al.	2015-09-24
Method and composition for enhancing cognition in alzheimer's patients Grant 9,119,846 - Zisapel , et al. September 1, 2	2015-09-01
CD44 splice variants in neurodegenerative diseases Grant 9,018,180 - Pinner , et al. April 28, 2	2015-04-28
Method for treating primary insomnia Grant 8,962,024 - Zisapel February 24, 2	2015-02-24
Method And Composition For Enhancing Cognition In Alzheimer's Patients App 20140377351 - ZISAPEL; Nava ; et al.	2014-12-25
Composition For Improving Cognition And Memory App 20140378512 - ZISAPEL; Nava ; et al.	2014-12-25
Composition for improving cognition and memory Grant 8,859,593 - Zisapel , et al. October 14, 2	2014-10-14
Method of treatment comprising administering controlled release melatonin Grant 8,728,511 - Zisapel , et al. May 20, 2	2014-05-20
Neuroprotective Peptides App 20140045764 - Pinner; Elhanan ; et al.	2014-02-13
Cytoplasmic malate dehydrogenase (MDH1) targeted treatment for neurodegenerative diseases Grant 8,461,297 - Zisapel , et al. June 11, 2	2013-06-11
2-aminobenzoyl derivatives Grant 8,309,767 - Zisapel , et al. November 13, 2	2012-11-13
Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions App 20120070501 - Zisapel; Nava ; et al.	2012-03-22
Method and formulation for treating resistance to antihypertensives and related conditions Grant 8,075,914 - Zisapel , et al. December 13, 2	2011-12-13
Cd44 Splice Variants In Neurodegenerative Diseases App 20110172286 - Pinner; Elhanan ; et al.	2011-07-14
Cytoplasmic Malate Dehydrogenase (mdh1) Targeted Treatment For Neurodegenerative Diseases App 20100279943 - Zisapel; Nava ; et al.	2010-11-04
Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions App 20080085317 - Zisapel; Nava ; et al.	2008-04-10
Indole derivatives Grant 7,355,054 - Zisapel , et al. April 8, 2	2008-04-08
Method and formulation for treating resistance to antihypertensives and related conditions Grant 7,332,177 - Zisapel , et al. February 19, 2	2008-02-19
2-Aminobenzoyl derivatives App 20060270733 - Zisapel; Nava ; et al.	2006-11-30
Composition for improving cognition and memory App 20060229340 - Zisapel; Nava ; et al.	2006-10-12
Pharmaceutical formulation comprising melatonin App 20050175692 - Zisapel, Nava	2005-08-11
Indole derivatives App 20050159463 - Zisapel, Nava ; et al.	2005-07-21
Indole derivatives Grant 6,858,642 - Zisapel , et al. February 22, 2	2005-02-22
Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them App 20050020664 - Zisapel, Nava ; et al.	2005-01-27
Methods for treating patients suffering from drug dependencies which lead to plasma melatonin deficiencies Grant 6,833,383 - Zisapel December 21, 2	2004-12-21
Method for treating primary insomnia App 20040248966 - Zisapel, Nava	2004-12-09
Derivating of tryptamine and analogous compounds and pharmaceutical formulations containing them Grant 6,780,884 - Zisapel , et al. August 24, 2	2004-08-24
Derivating of tryptamine and analogous componds and pharmaceutical formulations containing them App 20040029950 - Zisapel, Nava ; et al.	2004-02-12
Methods for treating patients suffering from drug dependencies which lead to plasma melatonin deficiencies App 20030040539 - Zisapel, Nava	2003-02-27
Methods for treating patients suffering from drug dependencies which leads to plasma melatonin deficiencies App 20020156121 - Zisapel, Nava	2002-10-24
Method for correcting plasma melatonin levels and pharmaceutical formulation comprising melatonin Grant 5,498,423 - Zisapel March 12, 1	1996-03-12
Melatonin antagonist Grant 4,880,826 - Zisapel , et al. November 14, 1	1989-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.